Can we talk about the fact that women have spent YEARS being confused, frightened, and sometimes completely dismissed when it comes to menopause treatment?
Because menopause hormone therapy is back in the headlines, and I think this conversation is long overdue.
This month, the American College of Obstetricians and Gynecologists (ACOG) published updated clinical guidance addressing hot flashes, sleep disturbances, and mood symptoms related to menopause.
Earlier this year, the FDA also approved changes to certain menopausal hormone therapy labels, including removing some risk statements from the boxed warnings.
And suddenly, we're seeing a lot of headlines suggesting that everything we thought we knew about hormone therapy has changed.
But here's the thing.
The science is more nuanced than either "hormones are dangerous" or "everyone should be taking hormones."
And women deserve to understand that nuance.
First, What Is Menopause Hormone Therapy?
Menopause hormone therapy, sometimes called hormone replacement therapy or HRT, involves using hormones to help manage certain symptoms associated with declining estrogen levels.
During perimenopause, estrogen and progesterone levels fluctuate. Eventually, after menopause, estrogen levels are generally lower.
These hormonal changes can contribute to symptoms such as:
-
Hot flashes and night sweats
-
Sleep disturbances
-
Vaginal dryness and discomfort
-
Pain with intercourse
-
Changes in mood and quality of life
There are different types of hormone therapy, and they're not interchangeable.
Systemic hormone therapy, which can be delivered through pills, patches, gels, or sprays, is used to treat symptoms such as hot flashes and night sweats.
Low-dose vaginal estrogen acts primarily in local tissues and can help with vaginal dryness and other symptoms of genitourinary syndrome of menopause (GSM).
The right treatment depends on the symptoms being addressed, the patient's medical history, and individual preferences.
So, What Actually Changed?
In February 2026, the FDA approved labeling changes for several menopausal hormone therapy products.
Certain warnings about cardiovascular disease, breast cancer, and probable dementia were removed from the prominent boxed-warning section.
But I want to emphasize something important:
Removing a boxed warning does not mean the risks have disappeared.
Relevant risks remain discussed elsewhere in product labeling, and different hormone formulations have different safety considerations.
This is why medical decisions should never be based on a headline alone.
The updated ACOG guidance also reinforces the importance of evidence-based treatment for bothersome menopause symptoms.
For many appropriately selected patients, systemic hormone therapy is an effective treatment for hot flashes and night sweats.
But it isn't appropriate for everyone.
Why Did Hormone Therapy Become So Controversial?
A lot of the fear surrounding menopausal hormone therapy traces back to the early 2000s, when findings from the Women's Health Initiative raised concerns about certain health risks.
Those findings were incredibly influential.
But over time, researchers have developed a more detailed understanding of how factors such as age, time since menopause, hormone formulation, and route of administration influence the balance of benefits and risks.
For example, the risks associated with starting systemic hormone therapy at age 52 may differ from those associated with starting it much later in life.
And low-dose vaginal estrogen is not the same treatment as systemic estrogen.
This is why broad statements like "HRT causes cancer" or "HRT is completely safe" are both misleading.
The details matter.
Let's Talk About Vaginal Health During Menopause
This is the part of the conversation I especially want more women to understand.
Estrogen helps maintain the vaginal epithelium, supports tissue elasticity, and influences the vaginal microbial environment.
As estrogen levels decline, vaginal tissues may become thinner, drier, and more vulnerable to irritation.
Some people also experience changes in the vaginal microbiome, including a reduction in certain Lactobacillus species.
This can contribute to symptoms associated with genitourinary syndrome of menopause, including dryness, burning, discomfort with sex, and some urinary symptoms.
And no, these symptoms are not something you simply have to accept because you're getting older.
Depending on your needs, treatment options may include vaginal moisturizers, lubricants, low-dose vaginal estrogen, and other prescription therapies.
A probiotic cannot replace estrogen treatment when estrogen-related tissue changes are the underlying issue.
I think that's an especially important distinction in the wellness industry.
Supporting your microbiome is one conversation. Treating hormone-related tissue changes is another.
What If You Don't Want Hormones?
That's a completely valid conversation to have with your healthcare professional.
There are nonhormonal prescription treatments for certain menopause symptoms, as well as behavioral approaches that can help some people.
The best option depends on which symptoms you're experiencing and how much they're affecting your life.
You don't need to feel pressured into hormone therapy.
But you also shouldn't feel frightened away from discussing it because of outdated information.
My Final Thoughts
Here's what I hope changes as menopause gets more attention:
I want women to stop being told that severe symptoms are just something they need to tolerate.
I want healthcare providers to take sleep disruption, vaginal discomfort, hot flashes, and changes in quality of life seriously.
And I want women to have access to accurate information about both hormonal and nonhormonal treatment options.
Menopause is a natural life stage. Suffering through untreated symptoms isn't a requirement.
The goal isn't to convince every woman to use hormones.
It's to make sure she has enough information to make the decision that's right for her.
Love,
Giana 💜
Biomedical Engineer, Women's Health Educator & Founder of With Meraki Co.